Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07158580 · ClinicalTrials.gov registry record
Opti Gait Wearable Gait Tracker
A clinical trial, sponsored by University of Wisconsin, Madison.
- Not yet
- Registry status
- 20
- Enrollment target
NCT07158580: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT07158580 is a clinical trial that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07158580 has not yet begun recruiting, sponsored by University of Wisconsin, Madison.
- NOT YET RECRUITING
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this observational study is to test a shoe mounted gait monitoring device that was refined with the input of older adults and assess the efficacy of the refinements through a series of tests that involve walking with and without the device.
Primary Outcome
Participants will walk 4 meters with and without the shoe mounted device to assess the change in walking speed
Interventions
- DEVICE Gait Tracker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-09 |
| Est. Completion | 2027-09 |
What is known before NCT07158580 opens enrollment
NCT07158580 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Gait Tracker is the first listed.
NCT07158580 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07158580 about?
NCT07158580 is a clinical study titled "Opti Gait Wearable Gait Tracker". The purpose of this observational study is to test a shoe mounted gait monitoring device that was refined with the input of older adults and assess the efficacy of the refinements through a series of tests that involve walking with and without the device.
What is the current status of trial NCT07158580?
This trial is currently not yet recruiting. The enrollment target is 20 participants. The study started on 2026-09. Estimated completion is 2027-09.
What interventions are being tested in trial NCT07158580?
The interventions under investigation include: Gait Tracker (DEVICE).
Who is sponsoring clinical trial NCT07158580?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia